ArticleCell reports. Medicine2024

CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer.

Raymond J Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.